-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Compared with warfarin, low molecular weight heparin (LMWH) can reduce cancer patients with recurrent venous thrombosis embolism (VTE) incidence
thrombus
Researchers used exact matching of cancer stage and propensity score matching to match patients 1:1, including cancer diagnosis, age, VTE year, and time from cancer diagnosis to index VTE
Original source:
Overall Survival with warfarin versus Low-Molecular-weight heparin in Cancer-Associated Thrombosis
in this message